Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says

Sandoz is on the hook for $39 million to Allergan and Duke University for infringing on their patent for an eyelash-growth drug, Latisse (bimatoprost ophthalmic solution), a Colorado federal jury decided Friday.